Sectra AB
STO:SECT B

Watchlist Manager
Sectra AB Logo
Sectra AB
STO:SECT B
Watchlist
Price: 327.4 SEK -0.85% Market Closed
Market Cap: 59.6B SEK

Wall Street
Price Targets

SECT B Price Targets Summary
Sectra AB

There are no price targets for SECT B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sectra AB Competitors:
Price Targets
ALC
Alcidion Group Ltd
36% Upside
5038
eWeLL Co Ltd
18% Upside
6095
MedPeer Inc
27% Downside
OMDA
Omda AS
27% Downside
CGS
CogState Ltd
28% Upside
2192
Medlive Technology Co Ltd
17% Upside
2150
CareNet Inc
14% Downside
328130
Lunit Inc
21% Upside

Revenue
Forecast

Revenue Estimate
Sectra AB

For the last 13 years the compound annual growth rate for Sectra AB's revenue is 7%. The projected CAGR for the next 3 years is 36%.

7%
Past Growth
36%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sectra AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Sectra AB

For the last 13 years the compound annual growth rate for Sectra AB's net income is 3%. The projected CAGR for the next 3 years is -4%.

3%
Past Growth
-4%
Estimated Growth
Estimates Accuracy
10%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SECT B's stock price target?
Not Available

SECT B doesn't have any price targets made by Wall Street professionals.

What is Sectra AB's Revenue forecast?
Projected CAGR
36%

For the last 13 years the compound annual growth rate for Sectra AB's revenue is 7%. The projected CAGR for the next 3 years is 36%.

What is Sectra AB's Net Income forecast?
Projected CAGR
-4%

For the last 13 years the compound annual growth rate for Sectra AB's net income is 3%. The projected CAGR for the next 3 years is -4%.

Back to Top